A Pilot Study of Tumor Vaccination and rhIL-7 Following Standard Multimodality Therapy in Patients with High Risk Pediatric Solid Tumors and Altered T Cell Homeostasis

Trial Profile

A Pilot Study of Tumor Vaccination and rhIL-7 Following Standard Multimodality Therapy in Patients with High Risk Pediatric Solid Tumors and Altered T Cell Homeostasis

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 26 Nov 2009

At a glance

  • Drugs Cancer vaccine; Dendritic cell vaccines; Interleukin-7
  • Indications Ewing's sarcoma; Neuroblastoma; Rhabdomyosarcoma; Sarcoma; Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 26 Nov 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top